General Information of the Compound
Compound ID
CP0528317
Compound Name
7-(2,7-diazaspiro[4.4]nonan-2-yl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine
    Show/Hide
Formula
C13H18N6
Molecular Weight
258.329
Canonical SMILES
Cc1cc(N2CCC3(CCNC3)C2)n2ncnc2n1
    Show/Hide
InChI
InChI=1S/C13H18N6/c1-10-6-11(19-12(17-10)15-9-16-19)18-5-3-13(8-18)2-4-14-7-13/h6,9,14H,2-5,7-8H2,1H3
    Show/Hide
InChIKey
KPSKRSDOPQQYCQ-UHFFFAOYSA-N
Physicochemical Property
logP
0.62252
Rotatable Bonds
1
Heavy Atom Count
19
Polar Areas
58.35
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4762217
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01962, Protein O-GlcNAcase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS